Changes in seroprevalence to hepatitis A in Victoria, Australia: A comparison of three time points.

Authors:
Address: School of Public Health and Community Medicine, University of New South Wales, Australia.
Journal:

Publication:

abstract

Serological data provide an important measure of past exposure and immunity to hepatitis A virus (HAV) infection in a population. National serosurveys from developed countries have typically indicated a decline in HAV seroprevalence over time as sanitation levels improve. We examined trends in the seroepidemiology of HAV antibodies in Victoria, Australia, drawing on cross-sectional samples taken at three time points over a 20-year period. Stored sera from 1988 (n=753), 1998 (n=1091), and 2008 (n=791) from persons aged 1-69 years were obtained from the state of Victoria, Australia. The within-year population adjusted results show a significant trend of increasing population HAV seroprevalence over time from 34.3% (95% CI 31.7-36.9) in 1988, to 40.0% (95% CI 37.1-42.8) in 1998 and 55.1% (95% CI 52.1-58.1) in 2008, P<0.0001. A particularly noticeable rise in population seroprevalence was observed between 1998 and 2008 for those aged 5-39 years. The increase in HAV seropositivity over time is in contrast to the declining rates of disease notification in Australia. Based on comparisons with other Australian data, it appears the increase in population seroprevalence over the last two decades is unlikely to be due to endemic transmission of infection. Instead, other factors, including increases in travel to HAV endemic regions, migration to Australia from HAV endemic regions and vaccine uptake are more likely causes. Ongoing monitoring of serological HAV profiles in the population is required to determine future policy direction to prevent increased burden.

Related Articles
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Seroepidemiology of hepatitis a in the croatian population.
Hepat Mon. 2011
Seroepidemiology of hepatitis a in the croatian population.
Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Hepat Mon. 2011 Dec; 11(12):997-9. Epub 2011 Dec 20.
Is there a change in cytomegalovirus seroepidemiology in Spain?
Eur J Epidemiol. 2004
Is there a change in cytomegalovirus seroepidemiology in Spain?
de Ory F, Ramírez R, García Comas L, León P, Sagües MJ, Sanz JC. Eur J Epidemiol. 2004; 19(1):85-9.
Review Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review.
Int J Infect Dis. 2010
Review Is there a link between seropositivity to Helicobacter pylori and hepatitis A virus? A systematic review.
BinSaeed AA. Int J Infect Dis. 2010 Jul; 14(7):e567-71. Epub 2010 Jan 13.
Review Declining hepatitis A seroprevalence: a global review and analysis.
Epidemiol Infect. 2004
Review Declining hepatitis A seroprevalence: a global review and analysis.
Jacobsen KH, Koopman JS. Epidemiol Infect. 2004 Dec; 132(6):1005-22.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.